In A First, Kerala Drugs Control Dept Files Complaint Against Divya Pharmacy In Kozhikode Court

Kozhikode: After the Supreme Court, yoga and ayurveda guru Baba Ramdev is set to face legal proceedings in Kerala over alleged misleading drug promotions. The Kerala government’s drugs control department is the first such state agency to file a case to prosecute Baba Ramdev and Divya Pharmacy he founded. He has been named third accused in the case, after the pharmacy and Acharya Balkrishna, chairman of Patanjali Ayurved. If convicted the duo could face a jail term of up to six months and a fine.

In its case, filed before the Judicial First Class Magistrate Court IV in Kozhikode, the department said that Divya Pharmacy had advertised pharmaceutical products that claimed to cure sexual impotence and diabetes. These are among the 54 diseases for which cure should not be advertised, under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Though the pharmacy has been repeatedly accused of violating drug laws, it eluded prosecution due to difficulties in filing cases. This time, however, the drugs regulator was emboldened by the Supreme Court’s intervention. Drugs controller Dr K Sujith Kumar ordered a statewide combing operation, involving 40 inspectors, to dig up violations. In Kozhikode region alone, 20 instances of violations were found, which forms the basis of the department case.

Shaji Varghese, the assistant drugs controller, sent a special team to Delhi to trace the people responsible for the advertisements. The case was initiated based on a complaint filed by Dr Babu K V, a health activist from Kannur.

“Repeated advertising by Patanjali, which involved even urging patients to stop taking insulin for type 1 diabetes and switch over to their products, can lead to a major public health crisis, with parents stopping insulin for children. I am certain the decisive intervention of the Supreme Court and prosecution by Kerala drug authorities will put an end to ongoing illegal advertising by Patanjali and other ayurveda companies,” said Dr Babu, who also played a decisive role in the case against Baba Ramdev in the SC.

Since 2022, he has filed over 100 RTI applications and complaints to halt alleged illegal drug promotions by Divya Pharmacy.

The Kerala government’s drugs control department is the first state agency to file a case to prosecute Baba Ramdev and Divya Pharmacy he founded. He has been named third accused in the case, after the pharmacy and Acharya Balkrishna, chairman of Patanjali Ayurved.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks